126 related articles for article (PubMed ID: 36154291)
1. First-In-Human Pilot PET Immunoimaging Study of
Wong JYC; Yamauchi DM; Adhikarla V; Simpson J; Frankel PH; Fong Y; Melstrom KA; Chen YJ; Salehian BD; Woo Y; Dandapani SV; Colcher DM; Poku EK; Yazaki PJ; Wu AM; Shively JE
Cancer Biother Radiopharm; 2023 Feb; 38(1):26-37. PubMed ID: 36154291
[No Abstract] [Full Text] [Related]
2. Phase I Study of Yttrium-90 Radiolabeled M5A Anti-Carcinoembryonic Antigen Humanized Antibody in Patients with Advanced Carcinoembryonic Antigen Producing Malignancies.
Akhavan D; Yazaki P; Yamauchi D; Simpson J; Frankel PH; Bading J; Colcher D; Poku K; Chen YJ; Lim D; Cristea M; Wu A; Shively J; Wong JYC
Cancer Biother Radiopharm; 2020 Feb; 35(1):10-15. PubMed ID: 31910346
[No Abstract] [Full Text] [Related]
3.
Mohajershojai T; Jha P; Boström A; Frejd FY; Yazaki PJ; Nestor M
Front Oncol; 2022; 12():849338. PubMed ID: 35433442
[TBL] [Abstract][Full Text] [Related]
4. Radioimmunoimaging of liver metastases with PET using a 64Cu-labeled CEA antibody in transgenic mice.
Nittka S; Krueger MA; Shively JE; Boll H; Brockmann MA; Doyon F; Pichler BJ; Neumaier M
PLoS One; 2014; 9(9):e106921. PubMed ID: 25226518
[TBL] [Abstract][Full Text] [Related]
5. Enhanced Therapeutic Effects of
Mohajershojai T; Spangler D; Chopra S; Frejd FY; Yazaki PJ; Nestor M
Cancers (Basel); 2023 Aug; 15(17):. PubMed ID: 37686514
[TBL] [Abstract][Full Text] [Related]
6. PEGylated Fluorescent Anti-carcinoembryonic Antigen Antibody Labels Colorectal Cancer Tumors in Orthotopic Mouse Models.
Turner MA; Amirfakhri S; Nishino H; Neel NC; Hosseini M; Cox KE; Lwin TM; Li L; Hong T; Sherman A; Shively JE; Hoffman RM; Yazaki PJ; Bouvet M
J Surg Res; 2023 Nov; 291():596-602. PubMed ID: 37540977
[TBL] [Abstract][Full Text] [Related]
7. Functional imaging of human epidermal growth factor receptor 2-positive metastatic breast cancer using (64)Cu-DOTA-trastuzumab PET.
Mortimer JE; Bading JR; Colcher DM; Conti PS; Frankel PH; Carroll MI; Tong S; Poku E; Miles JK; Shively JE; Raubitschek AA
J Nucl Med; 2014 Jan; 55(1):23-9. PubMed ID: 24337604
[TBL] [Abstract][Full Text] [Related]
8. A versatile bifunctional chelate for radiolabeling humanized anti-CEA antibody with In-111 and Cu-64 at either thiol or amino groups: PET imaging of CEA-positive tumors with whole antibodies.
Li L; Bading J; Yazaki PJ; Ahuja AH; Crow D; Colcher D; Williams LE; Wong JY; Raubitschek A; Shively JE
Bioconjug Chem; 2008 Jan; 19(1):89-96. PubMed ID: 17988078
[TBL] [Abstract][Full Text] [Related]
9. Humanization of the anti-CEA T84.66 antibody based on crystal structure data.
Yazaki PJ; Sherman MA; Shively JE; Ikle D; Williams LE; Wong JY; Colcher D; Wu AM; Raubitschek AA
Protein Eng Des Sel; 2004 May; 17(5):481-9. PubMed ID: 15316127
[TBL] [Abstract][Full Text] [Related]
10. Dose escalation trial of indium-111-labeled anti-carcinoembryonic antigen chimeric monoclonal antibody (chimeric T84.66) in presurgical colorectal cancer patients.
Wong JY; Chu DZ; Yamauchi D; Odom-Maryon TL; Williams LE; Liu A; Esteban JM; Wu AM; Primus FJ; Beatty JD; Shively JE; Raubitschek AA
J Nucl Med; 1998 Dec; 39(12):2097-104. PubMed ID: 9867150
[TBL] [Abstract][Full Text] [Related]
11. Investigation of Copper-64-Based Host-Guest Chemistry Pretargeted Positron Emission Tomography.
Jallinoja VIJ; Carney BD; Bhatt K; Abbriano CH; Schlyer DJ; Yazaki PJ; Houghton JL
Mol Pharm; 2022 Jul; 19(7):2268-2278. PubMed ID: 35700402
[TBL] [Abstract][Full Text] [Related]
12. Improved detection of medullary thyroid cancer with radiolabeled antibodies to carcinoembryonic antigen.
Juweid M; Sharkey RM; Behr T; Swayne LC; Rubin AD; Herskovic T; Hanley D; Markowitz A; Dunn R; Siegel J; Kamal T; Goldenberg DM
J Clin Oncol; 1996 Apr; 14(4):1209-17. PubMed ID: 8648376
[TBL] [Abstract][Full Text] [Related]
13. Anti-carcinoembryonic antigen antibodies versus somatostatin analogs in the detection of metastatic medullary thyroid carcinoma: are carcinoembryonic antigen and somatostatin receptor expression prognostic factors?
Behr TM; Gratz S; Markus PM; Dunn RM; Hüfner M; Schauer A; Fischer M; Munz DL; Becker H; Becker W
Cancer; 1997 Dec; 80(12 Suppl):2436-57. PubMed ID: 9406695
[TBL] [Abstract][Full Text] [Related]
14. Humanized Anti-Carcinoembryonic Antigen Antibodies Brightly Target and Label Gastric Cancer in Orthotopic Mouse Models.
Cox KE; Turner MA; Amirfakhri S; Lwin TM; Hosseini M; Ghosh P; Obonyo M; Murakami T; Hoffman RM; Yazaki PJ; Bouvet M
J Surg Res; 2024 Jan; 293():701-708. PubMed ID: 37839102
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibody imaging in patients with colorectal cancer and increasing levels of serum carcinoembryonic antigen. Experience with ZCE-025 and IMMU-4 monoclonal antibodies and proposed directions for clinical trials.
Patt YZ; Podoloff DA; Curley S; Smith R; Badkhamkar VA; Lamki LM; Jessup MM; Hohn DC
Cancer; 1993 Jun; 71(12 Suppl):4293-7. PubMed ID: 8389662
[TBL] [Abstract][Full Text] [Related]
16. A phase I radioimmunotherapy trial evaluating 90yttrium-labeled anti-carcinoembryonic antigen (CEA) chimeric T84.66 in patients with metastatic CEA-producing malignancies.
Wong JYC ; Chu DZ; Yamauchi DM; Williams LE; Liu A; Wilczynski S; Wu AM; Shively JE; Doroshow JH; Raubitschek AA
Clin Cancer Res; 2000 Oct; 6(10):3855-63. PubMed ID: 11051230
[TBL] [Abstract][Full Text] [Related]
17. A series of anti-CEA/anti-DOTA bispecific antibody formats evaluated for pre-targeting: comparison of tumor uptake and blood clearance.
Yazaki PJ; Lee B; Channappa D; Cheung CW; Crow D; Chea J; Poku E; Li L; Andersen JT; Sandlie I; Orcutt KD; Wittrup KD; Shively JE; Raubitschek A; Colcher D
Protein Eng Des Sel; 2013 Mar; 26(3):187-93. PubMed ID: 23175797
[TBL] [Abstract][Full Text] [Related]
18. A phase I trial of (90)Y-DOTA-anti-CEA chimeric T84.66 (cT84.66) radioimmunotherapy in patients with metastatic CEA-producing malignancies.
Wong JY; Chu DZ; Williams LE; Liu A; Zhan J; Yamauchi DM; Wilczynski S; Wu AM; Yazaki PJ; Shively JE; Leong L; Raubitschek AA
Cancer Biother Radiopharm; 2006 Apr; 21(2):88-100. PubMed ID: 16706629
[TBL] [Abstract][Full Text] [Related]
19. A humanized monoclonal antibody to carcinoembryonic antigen, labetuzumab, inhibits tumor growth and sensitizes human medullary thyroid cancer xenografts to dacarbazine chemotherapy.
Stein R; Goldenberg DM
Mol Cancer Ther; 2004 Dec; 3(12):1559-64. PubMed ID: 15634649
[TBL] [Abstract][Full Text] [Related]
20. Promising clinical performance of pretargeted immuno-PET with anti-CEA bispecific antibody and gallium-68-labelled IMP-288 peptide for imaging colorectal cancer metastases: a pilot study.
Touchefeu Y; Bailly C; Frampas E; Eugène T; Rousseau C; Bourgeois M; Bossard C; Faivre-Chauvet A; Rauscher A; Masson D; David A; Cerato E; Carlier T; Sharkey RM; Goldenberg DM; Barbet J; Kraeber-Bodere F; Bodet-Milin C
Eur J Nucl Med Mol Imaging; 2021 Mar; 48(3):874-882. PubMed ID: 32820369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
